Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Resivant Medical Receives FDA Clearance for Two Novel High-Viscosity Tissue Adhesive Products Cutiva™ Topical Skin Adhesive and Cutiva™ PLUS Skin Closure System
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Alternate Title:
RESIVANT-fda-approval
- Subject Terms:
- Abstract:
AKRON, Ohio, Aug. 23, 2024 /PRNewswire/ -- Resivant Medical announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its first two products, Cutiva™ Topical Skin Adhesive, and Cutiva PLUS™ Skin Closure System, which combines an adhesive mesh patch with high-viscosity Cutiva™ liquid adhesive. This achievement represents a significant advancement in medical tissue adhesive and wound closure technology and marks the first major adhesive advancement in over 25 years. [ABSTRACT FROM PUBLISHER]
No Comments.